BG102634A - New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain - Google Patents

New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain

Info

Publication number
BG102634A
BG102634A BG102634A BG10263498A BG102634A BG 102634 A BG102634 A BG 102634A BG 102634 A BG102634 A BG 102634A BG 10263498 A BG10263498 A BG 10263498A BG 102634 A BG102634 A BG 102634A
Authority
BG
Bulgaria
Prior art keywords
hydroxy
new
substituted
halogen
mandatorily
Prior art date
Application number
BG102634A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pamela Albaugh
Gang Liu
Keneth SHAW
Alan Hutchison
Original Assignee
Neurogen Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corporation filed Critical Neurogen Corporation
Publication of BG102634A publication Critical patent/BG102634A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
BG102634A 1996-01-19 1998-07-15 New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain BG102634A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/588,711 US5804686A (en) 1996-01-19 1996-01-19 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
PCT/US1997/000519 WO1997026243A1 (en) 1996-01-19 1997-01-14 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands

Publications (1)

Publication Number Publication Date
BG102634A true BG102634A (en) 1999-08-31

Family

ID=24354983

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102634A BG102634A (en) 1996-01-19 1998-07-15 New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain

Country Status (26)

Country Link
US (2) US5804686A (ru)
EP (1) EP1019372B1 (ru)
JP (1) JP2000503321A (ru)
KR (1) KR100490108B1 (ru)
CN (1) CN1209805A (ru)
AP (1) AP1015A (ru)
AT (1) ATE322480T1 (ru)
AU (1) AU1746697A (ru)
BG (1) BG102634A (ru)
BR (1) BR9707051A (ru)
CA (1) CA2243317C (ru)
CZ (1) CZ215498A3 (ru)
DE (1) DE69735647T2 (ru)
ES (1) ES2263170T3 (ru)
HU (1) HUP9901018A3 (ru)
IL (1) IL125391A (ru)
IS (1) IS4798A (ru)
MX (1) MX9805701A (ru)
NO (1) NO312670B1 (ru)
NZ (1) NZ330861A (ru)
OA (1) OA10811A (ru)
PL (1) PL327936A1 (ru)
RU (1) RU2167151C2 (ru)
SK (1) SK94398A3 (ru)
UA (1) UA49001C2 (ru)
WO (1) WO1997026243A1 (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
US6211365B1 (en) 1996-01-19 2001-04-03 Neurogen Corporation Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
AU2218997A (en) 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
US5723462A (en) * 1996-04-26 1998-03-03 Neurogen Corporation Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
ID24135A (id) * 1997-11-13 2000-07-06 Pfizer Prod Inc Metode sintesa pirol amida
GT199800179A (es) * 1997-11-13 2000-05-02 Procedimiento de sintesis de pirrol amidas.
WO1999043660A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
GB9812038D0 (en) 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US20050014939A1 (en) * 1999-08-31 2005-01-20 Neurogen Corporation Fused pyrrolecarboxamides: GABA brain receptor ligands
KR20020027613A (ko) * 1999-08-31 2002-04-13 해피 페너 ; 해리 에이치. 페너 2세 접합된 피롤카르복스아미드:가바 뇌 수용체 리간드
US6723332B2 (en) 2000-05-26 2004-04-20 Neurogen Corporation Oxomidazopyridine-carboxamides
MXPA03001951A (es) * 2000-09-06 2003-10-15 Neurogen Corp Pirroliminas y pirazoliminas fusionadas substituidas.
WO2002020492A1 (en) * 2000-09-06 2002-03-14 Neurogen Corporation Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
MXPA03004939A (es) * 2000-12-04 2003-09-10 Pfizer Prod Inc Sintesis de pirrolamidas.
JP2005525333A (ja) * 2002-02-07 2005-08-25 ニューロジェン コーポレイション 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物
EP1506194B1 (en) * 2002-05-17 2006-07-19 Neurogen Corporation SUBSTITUTED RING-FUSED IMIDAZOLE DERIVATES: GABA sb A /sb RECEPTOR LIGANDS
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
AU2007312936B2 (en) 2006-10-16 2013-09-26 Bionomics Limited Novel anxiolytic compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2959775A1 (en) 2010-08-31 2015-12-30 Meiji Seika Pharma Co., Ltd. Pest control agent
AU2012222874B2 (en) 2011-03-02 2015-04-16 Bionomics Limited Novel small-molecules as therapeutics
AU2012253237B2 (en) 2011-05-12 2015-09-24 Bionomics Limited Methods for preparing naphthyridines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) * 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3147276A1 (de) * 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3246932A1 (de) * 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU652968B2 (en) * 1990-10-09 1994-09-15 Neurogen Corporation Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
WO1993017025A1 (en) * 1992-02-19 1993-09-02 The Upjohn Company 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
WO1994017095A1 (en) * 1993-01-29 1994-08-04 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
NO312670B1 (no) 2002-06-17
AP1015A (en) 2001-09-28
US5804686A (en) 1998-09-08
IL125391A (en) 2004-07-25
HUP9901018A2 (hu) 1999-07-28
PL327936A1 (en) 1999-01-04
CZ215498A3 (cs) 1999-09-15
AP9801297A0 (en) 1998-09-30
NO983315D0 (no) 1998-07-17
OA10811A (en) 2001-07-05
NO983315L (no) 1998-09-03
CN1209805A (zh) 1999-03-03
CA2243317A1 (en) 1997-07-24
WO1997026243A1 (en) 1997-07-24
CA2243317C (en) 2007-09-25
DE69735647T2 (de) 2007-05-03
BR9707051A (pt) 1999-07-20
MX9805701A (es) 1998-11-30
US6080873A (en) 2000-06-27
NZ330861A (en) 2000-03-27
RU2167151C2 (ru) 2001-05-20
AU1746697A (en) 1997-08-11
KR19990077300A (ko) 1999-10-25
UA49001C2 (ru) 2002-09-16
EP1019372A1 (en) 2000-07-19
IS4798A (is) 1998-07-16
KR100490108B1 (ko) 2005-11-25
ATE322480T1 (de) 2006-04-15
EP1019372B1 (en) 2006-04-05
IL125391A0 (en) 1999-03-12
ES2263170T3 (es) 2006-12-01
SK94398A3 (en) 1999-02-11
HUP9901018A3 (en) 1999-11-29
DE69735647D1 (de) 2006-05-18
JP2000503321A (ja) 2000-03-21

Similar Documents

Publication Publication Date Title
BG102634A (en) New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain
OA09579A (en) Certain imidazoquinoxalines a new class of gaba brain receptor ligands
CA2175204A1 (en) Certain Fused Pyrrolecarboxanilides; a New Class of GABA Brain Receptor Ligands
TW369526B (en) Diazabicyclic neurokinin antagonists
MY107157A (en) Quinuclidine derivatives.
ATE253580T1 (de) Neue thieno(2,3-d)pyrimidindione, verfahren für ihre herstellung und ihre verwendung in der therapie
PL368409A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments
ATE387447T1 (de) Neue imidazo(1,5-c)chinazoline; eine neue klasse von liganden für gaba-rezeptoren im gehirn
BG104192A (en) Substituted 4-oxo-naphthyridine-3-carboxamides as gaba brain receptor ligands
BR9908321A (pt) Composto
DE60014339T8 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
DE69407407D1 (de) Ampa antagonisten und behandlungsmethode
DE69720515D1 (de) Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
DE69525738D1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
GB8701494D0 (en) Chemical compounds
NZ331769A (en) Indolomorphinan derivative and agent for curing and preventing cerebral disorder
CA2223936A1 (en) Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands
MX9703671A (es) Compuesto de aminometil arilo y ligandos selectivos del subtipo de receptor de la dopamina.
MX9700305A (es) Nuevos derivados de deazapurina; una clase de ligandos especificos del crf1.
MY107732A (en) Certain imidazoquinoxalines; a new class of gaba brain receptor ligands.
DE69907448D1 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden
AR007742A1 (es) Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro.
ES2181387T3 (es) Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.
CA2249562A1 (en) Certain fused pyrrolecarboxamides as gaba brain receptor ligands